- Home
- / MegaPro Biomedical
MegaPro Biomedical
Stock Price
NT$16.9
2024-10-29
Market Capitalization
NT$1.1 B
2024-10-29
MegaPro Biomedical Summary
Company Summary
- Overview
- MegaPro Biomedical (巨生生醫股份有限公司) is a company that develops nano iron oxide products. It offers anticancer drugs, injectable iron, magnetic resonance imaging (MRI) contrast, and other products.
- Type
- Public
- Status
- Active
- Founded
- 2014
- HQ
- TW | view all locations
- Website
- https://www.megaprobio.com/
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
MegaPro Biomedical Financials
Summary Financials
- Gross profit (FY, 2025)
- NT$727.0K
- Net income (FY, 2025)
- (NT$119.1M)
- Cash (FY, 2025)
- NT$112.3M
- EBIT (FY, 2025)
- (NT$119.2M)
- Enterprise value
- $945.5M
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026